Discovery of a First-in-Class Degrader for the Lipid Kinase PIKfyve
Chungen Li(Chinese Academy of Sciences), Ke Ding(China Pharmaceutical University), Yang Zhou(Beijing Tongren Hospital), Xia Jiang(Xuzhou Medical College), Fengtao Zhou(Jinan University), Lianchao Liu(Chinese Academy of Sciences), Xiaomei Ren(Chinese Academy of Sciences), Arul M. Chinnaiyan(University of Michigan), Zhen Wang(Shanghai Institute of Organic Chemistry), Yuanyuan Qiao(University of Michigan), Yang Zheng(Shanghai Ninth People's Hospital), Yuzhuo Wang(BC Cancer Agency), Yudi Qiu(Chinese Academy of Sciences), Caleb Cheng(University of Michigan), Weixue Huang(Chinese Academy of Sciences)
Cited by 18
Related Papers
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
|Nature Genetics|2013|1.2k
Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing
|Nature Genetics|2013|818
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
|Cancer Discovery|2013|737
Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
|Science Translational Medicine|2011|637